743 related articles for article (PubMed ID: 21528865)
1. Surface engineering of iron oxide nanoparticles for targeted cancer therapy.
Kievit FM; Zhang M
Acc Chem Res; 2011 Oct; 44(10):853-62. PubMed ID: 21528865
[TBL] [Abstract][Full Text] [Related]
2. Dextran-coated iron oxide nanoparticles: a versatile platform for targeted molecular imaging, molecular diagnostics, and therapy.
Tassa C; Shaw SY; Weissleder R
Acc Chem Res; 2011 Oct; 44(10):842-52. PubMed ID: 21661727
[TBL] [Abstract][Full Text] [Related]
3. Targeted superparamagnetic iron oxide nanoparticles for early detection of cancer: Possibilities and challenges.
Bakhtiary Z; Saei AA; Hajipour MJ; Raoufi M; Vermesh O; Mahmoudi M
Nanomedicine; 2016 Feb; 12(2):287-307. PubMed ID: 26707817
[TBL] [Abstract][Full Text] [Related]
4. Surface activation and targeting strategies of superparamagnetic iron oxide nanoparticles in cancer-oriented diagnosis and therapy.
Lin MM; Kim HH; Kim H; Dobson J; Kim DK
Nanomedicine (Lond); 2010 Jan; 5(1):109-33. PubMed ID: 20025469
[TBL] [Abstract][Full Text] [Related]
5. Theranostic Nanoparticles for RNA-Based Cancer Treatment.
Revia RA; Stephen ZR; Zhang M
Acc Chem Res; 2019 Jun; 52(6):1496-1506. PubMed ID: 31135134
[TBL] [Abstract][Full Text] [Related]
6. Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications.
Dadfar SM; Roemhild K; Drude NI; von Stillfried S; Knüchel R; Kiessling F; Lammers T
Adv Drug Deliv Rev; 2019 Jan; 138():302-325. PubMed ID: 30639256
[TBL] [Abstract][Full Text] [Related]
7. Multifunctional polymeric nanoparticles doubly loaded with SPION and ceftiofur retain their physical and biological properties.
Solar P; González G; Vilos C; Herrera N; Juica N; Moreno M; Simon F; Velásquez L
J Nanobiotechnology; 2015 Feb; 13():14. PubMed ID: 25886018
[TBL] [Abstract][Full Text] [Related]
8. Superparamagnetic iron oxide nanoparticles: amplifying ROS stress to improve anticancer drug efficacy.
Huang G; Chen H; Dong Y; Luo X; Yu H; Moore Z; Bey EA; Boothman DA; Gao J
Theranostics; 2013; 3(2):116-26. PubMed ID: 23423156
[TBL] [Abstract][Full Text] [Related]
9. Heparin-Superparamagnetic Iron Oxide Nanoparticles for Theranostic Applications.
Massironi N; Colombo M; Cosentino C; Fiandra L; Mauri M; Kayal Y; Testa F; Torri G; Urso E; Vismara E; Vlodavsky I
Molecules; 2022 Oct; 27(20):. PubMed ID: 36296711
[TBL] [Abstract][Full Text] [Related]
10. Superparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: opportunities and challenges.
Laurent S; Saei AA; Behzadi S; Panahifar A; Mahmoudi M
Expert Opin Drug Deliv; 2014 Sep; 11(9):1449-70. PubMed ID: 24870351
[TBL] [Abstract][Full Text] [Related]
11. Targeted Molecular Iron Oxide Contrast Agents for Imaging Atherosclerotic Plaque.
Evans RJ; Lavin B; Phinikaridou A; Chooi KY; Mohri Z; Wong E; Boyle JJ; Krams R; Botnar R; Long NJ
Nanotheranostics; 2020; 4(4):184-194. PubMed ID: 32637296
[No Abstract] [Full Text] [Related]
12. Significance of surface charge and shell material of superparamagnetic iron oxide nanoparticle (SPION) based core/shell nanoparticles on the composition of the protein corona.
Sakulkhu U; Mahmoudi M; Maurizi L; Coullerez G; Hofmann-Amtenbrink M; Vries M; Motazacker M; Rezaee F; Hofmann H
Biomater Sci; 2015 Feb; 3(2):265-78. PubMed ID: 26218117
[TBL] [Abstract][Full Text] [Related]
13. Surface-engineered magnetic nanoparticle platforms for cancer imaging and therapy.
Xie J; Liu G; Eden HS; Ai H; Chen X
Acc Chem Res; 2011 Oct; 44(10):883-92. PubMed ID: 21548618
[TBL] [Abstract][Full Text] [Related]
14. Selection of potential iron oxide nanoparticles for breast cancer treatment based on in vitro cytotoxicity and cellular uptake.
Poller JM; Zaloga J; Schreiber E; Unterweger H; Janko C; Radon P; Eberbeck D; Trahms L; Alexiou C; Friedrich RP
Int J Nanomedicine; 2017; 12():3207-3220. PubMed ID: 28458541
[TBL] [Abstract][Full Text] [Related]
15. Superparamagnetic iron oxide based nanoprobes for imaging and theranostics.
Lam T; Pouliot P; Avti PK; Lesage F; Kakkar AK
Adv Colloid Interface Sci; 2013 Nov; 199-200():95-113. PubMed ID: 23891347
[TBL] [Abstract][Full Text] [Related]
16. Targeting strategies for superparamagnetic iron oxide nanoparticles in cancer therapy.
Zhi D; Yang T; Yang J; Fu S; Zhang S
Acta Biomater; 2020 Jan; 102():13-34. PubMed ID: 31759124
[TBL] [Abstract][Full Text] [Related]
17. Preparation, Characterization, and In Vitro pH-sensitivity Evaluation of Superparamagnetic Iron Oxide Nanoparticle- Misonidazole pH-sensitive Liposomes.
Li B; Li B; He D; Feng C; Luo Z; He M
Curr Drug Deliv; 2019; 16(3):254-267. PubMed ID: 30426901
[TBL] [Abstract][Full Text] [Related]
18. Targeted extracellular vesicle delivery systems employing superparamagnetic iron oxide nanoparticles.
Zhuo Z; Wang J; Luo Y; Zeng R; Zhang C; Zhou W; Guo K; Wu H; Sha W; Chen H
Acta Biomater; 2021 Oct; 134():13-31. PubMed ID: 34284151
[TBL] [Abstract][Full Text] [Related]
19. Role of Surface Chemistry in Mediating the Uptake of Ultrasmall Iron Oxide Nanoparticles by Cancer Cells.
Narkhede AA; Sherwood JA; Antone A; Coogan KR; Bolding MS; Deb S; Bao Y; Rao SS
ACS Appl Mater Interfaces; 2019 May; 11(19):17157-17166. PubMed ID: 31017392
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
